The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Agreed
Looking strong!
Pleased I haven’t got a short on. My arse would be on fire.
Looks like the market is just shaking out some potential sellers before taking the next leg up.
Hahaha. The professionals have dumped an undervalued share to jump into one which did 600% yesterday. You do get some great laughs on here.
Haha I’m not sure I can agree with you on that one.
I’m not even interested in offloading, certainly not until the £1 is broken.
We hit 92p prior to news on India, design freeze, positives surrounding vaccine and antibodies. Also investor presentation detailing capacity increases reaching between 1000 - 2000%.
We have just started our rise back to fair value. In late August September I expect previous highs will be far behind us.
60p taken out. Lovely.
Time for a crumpet.
Great day here & the positives seem to just keep coming.
Initial news on the vaccine re antibodies is also promising. Granted the science behind antibodies has further to go so we cannot be certain of anything yet; However:
“Levels of T-cells peaked 14 days after vaccination and antibody levels peaked after 28 days.”
“The study showed 90% of people developed neutralising antibodies after one dose. Only ten people were given two doses and all of them produced neutralising antibodies. “
Imo, demand is simply going to be off the richter for this gold standard antibody test (should progress continue as expected). Hence why it’s labelled as a ‘game changer’. Especially with potential for it to be used alongside a successful vaccine.
You cannot argue with where this looks to be heading.
Regardless, 40% rise without official RNS is still a good day haha. Not quite sure what you were expecting?
We went down on news on India approval and design freeze... don’t take anything for granted.
Approaching 40% rise, this is without the groundbreaking updates we’re anticipating shortly.
Just shows how fast this can change.
I offloaded 4000 at 47p at marginal profit just to de-risk as that’s above my average and I’ve been nursing a paper loss for a while.
I’ll be holding the remaining 32,000 for £1 as things stand. Trading in the dips and if it goes sub 40 again I’ll happily load up another 8000 shares.
Each to their own and that but you’ve really got to wonder at the sells going through at 41p this morning.
SNG perfect example of the share price only matters when you sell.
ODX will do very well, just have to wait for the market to realise its value.
Imo the placing, speed ticket RNS & negativity surrounding PR has brought this down to current levels. At 36p I think it’s a joke. But a great time to build a position nonetheless.
I think minimum fair value right now is at least 25/30% above the current SP. Rising further as key developments in the pipeline are ticked off leading to what I’d expect are orders from both the U.K. and around the globe. Just use the most conservative figures possible from the revenue streams being developed to show an MCap multiples of the current.
As per the Covid-19 tests; Since capacity (which is to be increased substantially) can be altered to suit whichever test is in demand it actually de-risks this a lot for me. We haven’t got our eggs in one basket like some other similarly placed companies. But will eventually be able to pick and choose which tests to produce, whether these are antibody/antigen for either centralised or decentralised locations. Which ensures we cover as much of the market as possible. Whilst Minimum 200,000 capacity is agreed for the RTC @ approx. (I think?) 75p profit per test. (£7,200,000 per annum) ODX may (likely imo) find themselves receiving far more lucrative contracts from elsewhere for this or any one of their tests.
As a holder I think it may take a while to get back to a more accurate SP unless of course we hit the roof next week. But come September I’m anticipating previous highs will be well behind us.
Beyond anything, Omega and various others are doing brilliant work in the fight against this brutal virus.
As always IMO. Please DYOR.
52p
Ghia; Yes.
Especially when it’s becoming more likely a successful vaccine will require boosters more often. Whilst it seems the antibody response to the virus various amongst each individual. I may be wrong, but I don’t think you could for example pinpoint a 1 year booster for everyone. Everyone’s immune system is different and likewise the antibody test could help identify each individuals level of immunity over the future years.
Just my thoughts.
However, regardless of whether this is or isn’t the case. Demand will far outweigh what ODX can provide at full capacity anyway. Especially as the news spreads around the globe.
Firstly, if the science for antibodies suggests they do not provide immunity then unfortunately vaccine hopes are likely dashed. But since there’s been no reinfection to date along with the positivity surrounding vaccine trials in the media I’d expect this is unlikely to be the case.
For me it’s becoming increasingly likely the antibody tests will be used in tandem with vaccinations. If science suggests antibodies provide immunity for 6 - 12 months, antibody testing will be an ideal tool to check this. From an investment view, this will require an even greater number of tests than what’s already expected over many years to come.
Regardless, one thing which is for certain is demand for these products will not be the problem, it will be the supply. Which is already in the process or being increased almost 1000% as it stands. Without mentioning the other Covid tests.
Brilliant news!
Was hoping for one last buy in the low 30s but I’d expect that could be well and truly off the tables now.
Let’s hope the rerate can begin and we can get back into the 50s and 60s soon before long.
The tests which have been purchased by the government so far have been far below the MHRA’s targets of 98% sensitivity and 98% specificity.
the government agreed to buy £13.56m worth of tests from Roche until the PHE evaluation reported it had far lower results than they were told I.e 83.9% sensitivity. Likewise £16m for poor tests imported from China and similarly those produced by Abbott all failing to meet standards.
After so many failures, I think the government are keen on ensuring they have a test which they know is the ‘game changer’ before they go and throw another stack of cash at it. Whilst the time spent by the consortium on meticulously perfecting their product (particularly Abingdon Health) suggests to me this could well be the one, fingers crossed.
I believe the science already shows the body produces antibodies from coronavirus, it’s more case of do they last, for a month, 6 months a year? Which is why it’s becoming likely the vaccine will require boosters more often. Antibody tests sounds to me like an ideal way to confirm whether your currently immune or not.
But the fact there’s no reported cases of reinfection gives me every confidence the science behind antibodies providing immunity will be successful & if the test is passed by PHE it could well be game on for Omega.
It’s known antibodies remain in the body once you’ve had coronavirus, I just don’t think we know for how long yet.
However, as mentioned. There hasn’t been any reports of reinfection which quite obviously suggests antibodies are important. If they’re not we can simply knock any vaccine hopes on the head. Which would be strange given all the positive publicity they’ve been getting recently.
Imo there will be a vaccine, however, it’s likely to be one which will require boosters more frequently. I wonder what’s the best way to check if your vaccine antibodies are still working as they should?.. Exactly.
ODX will eventually have capacity for 1,000,000 rising to 2,000,000 test per week. Worst case scenario the capacity is reserved for predominantly antigen tests. Which we now know are going to be in even greater demand in the U.K. nevermind around the globe.
And at the current market cap. I think all negativity is pretty much priced in. Especially in the long term.
As always. IMO.
Interesting. If the science is unproven on antibody tests then surely we must be wasting our time with vaccine also?
If Hand**** pulls it out the bag this afternoon, tomorrow could be very interesting there’s no doubting that mate!